Accuracy and safety of 99mTc-labeled anti-D-dimer (DI-80B3) Fab’ fragments (ThromboView®) in the diagnosis of deep vein thrombosis: A phase II study

Bates, 2012, American College of Chest Physicians. Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 141, e351S, 10.1378/chest.11-2299 Brotman, 2003, Limitations of D-dimer testing in unselected patients with suspected venous thromboembolism, Am J Med, 114, 276, 10.1016/S0002-9343(02)01520-6 Heijboer, 1992, Clinical utility of real-time compression ultrasonography for diagnostic management of patients with recurrent venous thrombosis, Acta Radiol, 33, 297, 10.3109/02841859209173182 Bettman, 1977, Leg phlebography; the incidence, nature, and modification of undesirable side-effects, Radiology, 122, 101, 10.1148/122.1.101 Bounameaux, 2008, Venous thromboembolism: contemporary diagnostic and therapeutic aspects, Vasa, 37, 211, 10.1024/0301-1526.37.3.211 Morris, 2004, Single photon emission computed tomography of pulmonary emboli and venous thrombi using anti-D-dimer, Am J Respir Crit Care Med, 169, 987, 10.1164/rccm.200306-735OC Macfarlane, 2009, Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab' fragment (99mTc-DI-DD3B6/22-80B3): results of a phase I trial, Eur J Nucl Med Mol Imaging, 36, 250, 10.1007/s00259-008-0934-7 Wells, 2003, Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis, N Engl J Med, 349, 1227, 10.1056/NEJMoa023153 Rylatt, 1983, An immunoassay for human D dimer using monoclonal antibodies, Thromb Res, 31, 767, 10.1016/0049-3848(83)90108-1 Lamoyi, 1983, Preparation of F(ab')2 fragments from mouse IgG of various subclasses, J Immunol Methods, 56, 235, 10.1016/0022-1759(83)90415-5 Rabinov, 1972, Roentgen diagnosis of venous thrombosis in the leg, Arch Surg, 104, 134, 10.1001/archsurg.1972.04180020014004 Macfarlane, 2006, Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab', Eur J Nucl Med Mol Imaging, 33, 648, 10.1007/s00259-005-0025-y Trotti, 2003, CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment, Semin Radiat Oncol, 13, 176, 10.1016/S1053-4296(03)00031-6 Guevara, 1993, Heparin-induced transaminase elevations: a prospective study, Int J Clin Pharmacol Ther Toxicol, 31, 137 Morris, 2004, Improved imaging of deep venous thrombi during anticoagulation using radiolabelled anti-D-dimer antibodies, Nucl Med Commun, 25, 917, 10.1097/00006231-200409000-00009 Tan, 2009, Diagnostic management of clinically suspected acute deep vein thrombosis, Br J Haematol, 146, 347, 10.1111/j.1365-2141.2009.07732.x Kearon, 2012, Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e419S Morris, 2011, Detection of pulmonary emboli with (99m)Tc-labelled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView), Am J Respir Crit Care Med, 184, 708, 10.1164/rccm.201104-0624OC Morris, 2011, Pulmonary emboli imaging with (99m)Tc-labelled anti-D-dimer (DI-80B3) Fab' followed by SPECT, Heart Lung Circ, 20, 503, 10.1016/j.hlc.2011.03.113